MedTrace Logo

Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension

NCT00325637 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2008-12-12

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of cilnidipine (a calcium channel blocker) and losartan (an angiotensin II receptor blocker) on cerebral blood flow (CBF) and blood pressure in hypertensive patients with a previous ischemic stroke.

Conditions

Interventions

DRUG

cilnidipine

Cilnidipine 10\~20mg, qd, po for 4 weeks.

Sponsors & Collaborators

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Seong H Park, Professor · Seoul National University Budang Hospital

  • Jeong H Rha, Professor · Inha University Hospital

  • Ja S Koo, Professor · Eulji General Hospital

  • Keun S Hong, Professor · Inje University Ilsan Paik Hospital

  • Yong S Lee, Professor · Seoul National University Boramae Hospital

  • Dong W Kang, Assistant Professor · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-07-31
Completion
2007-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00325637 on ClinicalTrials.gov